ANXA1 and colitis: Additionally, the therapeutic administration of nanoparticles containing the AnxA1 mimetic peptide Ac2-26 after DSS withdrawal produced a faster recovery of the colitis symptoms as compared to mice that were inoculated with nanoparticles containing a scrambled peptide [78].